- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03309748
Photodynamic Remediation of Black Stain
Remediation of Adult Black Dental Stains by Photodynamic Therapy
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The standard treatment practice for black dental stain is dental prophylaxis, however this is often harmful to the enamel surface and can result in tooth sensitivity. In this study we aim to explore the application of antimicrobial photodynamic therapy (aPDT) for the treatment of adult black dental stain. aPDT has demonstrated positive results in the treatment of periodontitis.
Patients received an oral examination and the extent of black stain was scored (score 1, pigmented spots or incomplete lines parallel to the gingival margin, score 2: solid lines pigmented, readily observable and limited to the cervical third of the tooth surface, score 3: pigmentation extending beyond the cervical third). The patients' oral cavity was photographed in sextants, along with a complete picture of the jaw (lingual plane) and the maxillary arch (palatal plane). For bacterial analysis, 1mg of black plaque was collected by scraping with a plastic scaler from buccal tooth surfaces taking care to avoid unnecessary removal of enamel hydroxyapatite. The first dental prophylaxis was performed to remove the black stain.
Patients were reviewed monthly and in each visit, were photographed as previously described, and the level of pigmentation scored according to the mentioned criteria. The monthly visits were continued until the black stain score returned to the initial value. The period between the first and the last appointment was noted. At this point, each volunteer received dental prophylaxis once again, followed by the application of aPDT. Antimicrobial photodynamic therapy was applied to 31 orally healthy volunteers with black stained teeth, using the GLO home whitening device (GLO™ Science LLC, New York, USA) in 2 cycles of 8 minutes. Outcome variables were area, color and time taken to reappearance of black stain following dental prophylaxis with and without antimicrobial photodynamic therapy. Differences in bacterial composition of black stain (specifically Aggregatibacter actinomycetemcomitans, Tannerella forsythia and Porphyromonas gingivalis) were analyzed DNA extracted from plaque samples. Following the application of aPDT, patients were reviewed monthly until the black stain score returned to the initial value.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Volunteers with black stained (plaque on) teeth
Exclusion Criteria:
- Children
- Pregnant women
- Volunteers having completed antibiotic therapy during 15 days prior to the start of the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NON_RANDOMIZED
- Interventional Model: CROSSOVER
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Dental Prophylaxis
Standard dental prophylaxis
|
American Dental Association, Code on Dental Procedures and Nomenclature (CDT) CDT code D1110
|
ACTIVE_COMPARATOR: Dental prophylaxis + antimicrobial photodynamic therapy
Dental prophylaxis + aPDT
|
American Dental Association, Code on Dental Procedures and Nomenclature (CDT) CDT code D1110
Dental prophylaxis using American Dental Association, Code on Dental Procedures and Nomenclature (CDT) CDT code D1110 followed by two 8-minute irradiation cycles using GLO Brilliant home use whitening device (GLO ™ Science LLC, New York, USA).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Restoration period
Time Frame: The period of time required for the restoration of the black stain to pre-cleaning levels will be determined by measurements carried out during Weeks 18-24, post-application of each treatment arm
|
Time to restoration of the black stain following each treatment arm
|
The period of time required for the restoration of the black stain to pre-cleaning levels will be determined by measurements carried out during Weeks 18-24, post-application of each treatment arm
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Black stain color
Time Frame: The depth of color of the black stain will be measured at Week 20 following the application of each treatment arm
|
Color of the black stain
|
The depth of color of the black stain will be measured at Week 20 following the application of each treatment arm
|
Black stain area
Time Frame: Area covered by the black stain will be carried out at Week 20 following the application of each treatment arm
|
Area covered by the black stain
|
Area covered by the black stain will be carried out at Week 20 following the application of each treatment arm
|
Microbial composition
Time Frame: Black plaque sampling will be carried out at Week 0, followed by a second sampling at Week 20, following the application of each treatment arm, in accordance with the reappearance rate of the black stain in each study volunteer
|
Microbial composition of the black plaque
|
Black plaque sampling will be carried out at Week 0, followed by a second sampling at Week 20, following the application of each treatment arm, in accordance with the reappearance rate of the black stain in each study volunteer
|
Collaborators and Investigators
Sponsor
Investigators
- Study Director: Maria del Mar Jovani Sancho, PhD, Cardenal Herrera University
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UCHCEU INDI-1531
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dental Deposits
-
Marmara UniversityCompletedPlaque, DentalTurkey
-
Damascus UniversityCompleted
-
Heba sabbaghCompleted
-
Azienda Ospedaliera Città della Salute e della...Recruiting
-
Colgate PalmoliveCompleted
-
Church & Dwight Company, Inc.Completed
-
Damascus UniversityCompletedPlaque, DentalSyrian Arab Republic
-
Novozymes A/SUniversity of AarhusRecruitingDental Biofilm AccumulationDenmark
-
Kocaeli UniversityCompletedDental PlaqueTurkey
-
PfizerCompleted
Clinical Trials on Dental prophylaxis
-
Massachusetts General HospitalHarvard School of Dental MedicineCompletedPeriodontal Disease | Type II DiabetesUnited States
-
University Hospital HeidelbergUnknownRheumatoid Arthritis | Periodontitis | Gingivitis | Dental ProphylaxisGermany
-
University of PittsburghEnrolling by invitationPeri-Implantitis | Bleeding of Subgingival SpaceUnited States
-
University of PennsylvaniaMedical University of South Carolina; NYU Langone Health; National Institute... and other collaboratorsTerminatedHead and Neck Cancer | Oral MucositisUnited States
-
Lutheran University of BrazilCompletedTooth Discoloration | Dental Calculus
-
Cardenal Herrera UniversityCompleted
-
Universidad Complutense de MadridRecruitingDesquamative GingivitisSpain
-
Biruni UniversityRecruiting
-
Grupo de Investigação em Bioquímica e Biologia...University of LisbonUnknown
-
University of BarcelonaCompletedType 2 Diabetes Mellitus | Chronic Periodontitis